Immunotherapy and cell therapy have revolutionized the field of cancer treatment by harnessing the power of the immune system to fight cancer cells. However, the development of effective immunotherapy drugs such as immune checkpoint inhibitors requires extensive preclinical testing to ensure safety and efficacy. Breakthroughs in the field are faced with several challenges including the generation of appropriate humanized mouse models for preclinical evaluation. Among others, genetically-engineered mouse models have emerged as valuable tools for improving cancer treatment outcomes.
Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs
July 13, 2023
- Large Panel Design to Identify Human and Mouse Lymphocyte Subsets Using Cytek® Aurora Flow Cytometers
- Featured Guest Blog: Cardiac Stem Cells by Darcey L. Clark
- The Technology Behind Spectral Flow Cytometry
- Outrunning Resistance: Why Preclinical Insight Is the Key to Durable Oncology Therapies
- New Cytometric Horizons using Spectral Flow Cytometry
Large Panel Design to Identify Human and Mouse Lymphocyte Subsets Using Cytek® Aurora Flow Cytometers
By Duangchan Suwannasaen PhD, Scientist
The Technology Behind Spectral Flow Cytometry
By Jayne Schaubhut, Lab Supervisor
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.